Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Eton Pharmaceuticals (ETON) Other Gross PP&E Adjustments (2019 - 2025)

Eton Pharmaceuticals' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at -$1.3 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments fell 652.3% year-over-year to -$1.3 million; the TTM value through Sep 2025 reached -$1.3 million, down 652.3%, while the annual FY2024 figure was $105000.0, 103.49% up from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was -$1.3 million at Eton Pharmaceuticals, down from -$534000.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $341000.0 in Q1 2024 and bottomed at -$3.0 million in Q4 2023.
  • The 5-year median for Other Gross PP&E Adjustments is $200000.0 (2023), against an average of -$183631.6.
  • The largest annual shift saw Other Gross PP&E Adjustments surged 116.3% in 2022 before it plummeted 1141.87% in 2023.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.8 million in 2021, then soared by 116.3% to $289000.0 in 2022, then tumbled by 1141.87% to -$3.0 million in 2023, then skyrocketed by 103.49% to $105000.0 in 2024, then tumbled by 1357.14% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for ETON's Other Gross PP&E Adjustments are -$1.3 million (Q3 2025), -$534000.0 (Q2 2025), and -$173000.0 (Q1 2025).